Table 2.
Bivariate linear regression of average muscle loss per day.
| Predictor | Estimate | SE | Lower CI | Upper CI | p |
|---|---|---|---|---|---|
| Age | 1.79E−05 | 6.67E−05 | − 1.13E−04 | 1.49E−04 | 0.789 |
| Female gender | 6.33E−04 | 2.23E−03 | − 3.74E−03 | 5.00E−03 | 0.776 |
| BMI (kg/m2) | 4.58E−04 | 1.56E−04 | 1.52E−04 | 7.64E−04 | 0.004 |
| Psoas Area (in cm2) | 1.20E−04 | 1.68E−04 | − 2.09E−04 | 4.49E−04 | 0.476 |
| SATArea (in cm2) | − 5.57E−06 | 7.55E−06 | − 2.04E−05 | 9.23E−06 | 0.462 |
| VATArea (in cm2) | 4.89E−06 | 9.49E− 06 | − 1.37E−05 | 2.35E−05 | 0.607 |
| Disease entity | 8.90E−03 | 1.99E−03 | 5.00E−03 | 1.28E−02 | 0.001 |
| Preconditions | 6.38E−03 | 2.24E−03 | 1.99E−03 | 1.08E−02 | 0.005 |
| Art. hypertention | 3.67E−03 | 1.97E−03 | − 1.91E−04 | 7.53E−03 | 0.064 |
| Diabetes | 2.76E−03 | 2.54E−03 | − 2.22E−03 | 7.74E−03 | 0.278 |
| Cardio-vascular | 2.24E−03 | 2.19E−03 | − 2.05E−03 | 6.53E−03 | 0.307 |
| Pulmonal | − 7.56E−04 | 2.86E−03 | − 6.36E−03 | 4.85E−03 | 0.792 |
| Malignant | 4.02E−03 | 2.84E−03 | − 1.55E−03 | 9.59E−03 | 0.159 |
| Hospitalization (days) | 7.32E−05 | 1.17E−05 | 5.03E−05 | 9.61E−05 | 0.001 |
| ICU stay (days) | 8.05E−05 | 1.54E−05 | 5.03E−05 | 1.11E−04 | 0.001 |
| Days of IMV | 8.03E−05 | 2.13E−05 | 3.86E−05 | 1.22E−04 | 0.001 |
| Highest SOFA | 8.54E−04 | 5.12E−04 | − 1.50E−04 | 1.86E−03 | 0.101 |
| Overweight | 3.53E−03 | 2.03E−03 | − 4.49E−04 | 7.51E−03 | 0.084 |
| Obesity | 4.80E−03 | 2.21E−03 | 4.68E−04 | 9.13E−03 | 0.032 |
| Sarcopenia | − 9.19E−05 | 9.19E−05 | − 2.72E−04 | 8.82E−05 | 0.319 |
| Sarcopenic obesity | 3.22E−03 | 2.57E−03 | − 1.82E−03 | 8.26E−03 | 0.211 |
Significant variables are printed in bold. BMI, Body Mass Index, SAT, Subcutaneous Adipose Tissue, VAT, Visceral Adipose Tissue, ICU, Intensive Care Unit, IMV, Invasive Mechanical Ventilation, SOFA, Sequential Organ Failure Assessment. CI, Confidence interval.